JP2013536419A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536419A5
JP2013536419A5 JP2013524450A JP2013524450A JP2013536419A5 JP 2013536419 A5 JP2013536419 A5 JP 2013536419A5 JP 2013524450 A JP2013524450 A JP 2013524450A JP 2013524450 A JP2013524450 A JP 2013524450A JP 2013536419 A5 JP2013536419 A5 JP 2013536419A5
Authority
JP
Japan
Prior art keywords
tmab
monoclonal antibody
antibody
alternative
agg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013524450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013536419A (ja
JP5805190B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/064178 external-priority patent/WO2012022774A1/en
Publication of JP2013536419A publication Critical patent/JP2013536419A/ja
Publication of JP2013536419A5 publication Critical patent/JP2013536419A5/ja
Application granted granted Critical
Publication of JP5805190B2 publication Critical patent/JP5805190B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013524450A 2010-08-19 2011-08-17 療法用モノクローナル抗体に結合する抗体の測定のためのアッセイ Active JP5805190B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10173408.5 2010-08-19
EP10173408 2010-08-19
PCT/EP2011/064178 WO2012022774A1 (en) 2010-08-19 2011-08-17 An assay for measurement of antibodies binding to a therapeutic monoclonal antibody

Publications (3)

Publication Number Publication Date
JP2013536419A JP2013536419A (ja) 2013-09-19
JP2013536419A5 true JP2013536419A5 (cg-RX-API-DMAC7.html) 2014-04-24
JP5805190B2 JP5805190B2 (ja) 2015-11-04

Family

ID=42727619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013524450A Active JP5805190B2 (ja) 2010-08-19 2011-08-17 療法用モノクローナル抗体に結合する抗体の測定のためのアッセイ

Country Status (7)

Country Link
US (1) US9081016B2 (cg-RX-API-DMAC7.html)
EP (1) EP2606362B1 (cg-RX-API-DMAC7.html)
JP (1) JP5805190B2 (cg-RX-API-DMAC7.html)
CN (1) CN103109190B (cg-RX-API-DMAC7.html)
CA (1) CA2802278A1 (cg-RX-API-DMAC7.html)
ES (1) ES2555864T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012022774A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104614535B (zh) * 2015-02-10 2017-11-28 深圳市新产业生物医学工程股份有限公司 甲状腺微粒体抗体检测试剂盒及其制备方法和应用
US11119096B2 (en) * 2016-07-08 2021-09-14 W. Health L.P. Universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
CN106093413A (zh) * 2016-07-18 2016-11-09 本·沙朗 一种抗英夫利西抗体elisa检测试剂盒和检测方法
CA3075900A1 (en) * 2017-09-15 2019-03-21 Beckman Coulter, Inc. Flow based assays for therapeutics
US20190302124A1 (en) * 2018-03-27 2019-10-03 Laboratory Corporation Of America Holdings Compositions and Methods for Identifying Subjects Who May Benefit From Treatment With Therapeutic Agents
JP7570421B2 (ja) * 2020-01-02 2024-10-21 エフ. ホフマン-ラ ロシュ アーゲー Ada応答特定アッセイ
CN115552244A (zh) * 2020-05-08 2022-12-30 豪夫迈·罗氏有限公司 用于高药物耐受性测试的高离子强度解离测定
CN117590002B (zh) * 2023-11-23 2024-10-22 上海领检科技有限公司 一种TNFα抗药抗体的检测方法及检测试剂盒

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508132A (en) 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4628037A (en) 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US4695393A (en) 1983-05-12 1987-09-22 Advanced Magnetics Inc. Magnetic particles for use in separations
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4698302A (en) 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
JPH0823558B2 (ja) 1984-11-27 1996-03-06 オ−ジエニクス リミテツド 検定装置
EP0222146B1 (de) 1985-10-16 1994-02-16 Fresenius AG Selektives Adsorbens zur Bindung von Immunkomplexen
WO1987002778A1 (en) 1985-10-22 1987-05-07 Cooper-Lipotech Solid-phase liposome immunoassay system
US6316607B1 (en) 1986-04-30 2001-11-13 Igen International, Inc. Electrochemiluminescent assays
US4965392A (en) 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5935779A (en) 1988-11-03 1999-08-10 Igen International Inc. Methods for improved particle electrochemiluminescence assay
GB8803000D0 (en) 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
ZA898290B (en) 1988-11-03 1991-06-26 Igen Inc Electrochemiluminescent assays
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
EP0448632A1 (en) 1988-12-09 1991-10-02 Centocor, Inc. Anti-idiotopic immunometric assay
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5364930A (en) 1990-10-16 1994-11-15 Northwestern University Synthetic C1q peptide fragments
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
US5516635A (en) 1991-10-15 1996-05-14 Ekins; Roger P. Binding assay employing labelled reagent
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
US5466416A (en) 1993-05-14 1995-11-14 Ghaed; Ali Apparatus and methods for carrying out electrochemiluminescence test measurements
US6241963B1 (en) 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
DE19806989A1 (de) 1998-02-19 1999-08-26 Roche Diagnostics Gmbh Erzeugung räumlich scharf begrenzter Festphasen für Bindungsassays
IT1315254B1 (it) 1999-11-05 2003-02-03 Diesse Diagnostica Senese Spa Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc.
EP1230552B1 (en) 1999-11-16 2006-01-11 Genentech, Inc. Elisa for vegf
CA2543830A1 (en) 2003-10-27 2005-05-19 Monogram Biosciences, Inc. Detecting human anti-therapeutic antibodies
DE102004052729A1 (de) * 2004-10-30 2006-05-04 Roche Diagnostics Gmbh Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten
SI3264094T1 (sl) * 2005-04-04 2021-04-30 Biogen Ma Inc. Metode za ocenjevanje imunskega odziva na terapevtsko učinkovino
EP2389947A1 (en) * 2006-03-23 2011-11-30 Novartis AG Anti-tumor cell antigen antibody therapeutics
AU2007307652A1 (en) * 2006-10-10 2008-04-17 Squicor Compositions and methods for treating and diagnosing cancers
US8501417B2 (en) * 2007-06-26 2013-08-06 Vanderbilt University Immunological compositions as cancer biomarkers and/or therapeutics

Similar Documents

Publication Publication Date Title
JP2013536419A5 (cg-RX-API-DMAC7.html)
JP6715770B2 (ja) モノクローナル抗tk1抗体
JP7105970B1 (ja) SARS-CoV-2の免疫測定方法及び免疫測定キット
JP2018535404A5 (cg-RX-API-DMAC7.html)
RU2009116611A (ru) Твердофазный иммуноферментный анализ (elisa) для фактора роста эндотелия сосудов (vegf)
JP5586368B2 (ja) 腫瘍マーカーとしてのn1,n12−ジアセチルスペルミン
FI3356827T3 (fi) GDF-15 diagnostisena markkerina immuunivasteen vapauttajilla annetun hoidon hoitovasteen ennustamiseksi
CN102884433A (zh) 用于检测抗体的方法
ES2555864T3 (es) Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico
CN104736561A (zh) 帕潘立酮的抗体及其用途
CN108700581A (zh) 用于定量生物试样中的测定对象物质的试剂盒及定量生物试样中的测定对象物质的方法
US20100015643A1 (en) Method of quantitative determination of antigen protein and quantitative determination kit therefor
JP2024167177A (ja) ヌクレオシド逆転写酵素インヒビター治療に準拠したモニタリングのための製品および方法
CN111308085B (zh) 一种超敏心肌肌钙蛋白i检测方法和试剂盒
CN109870581B (zh) 一种定量检测HBsAg的试剂盒及方法
Liu et al. A novel approach to remove interference of therapeutic monoclonal antibody with serum protein electrophoresis
JP2017120263A (ja) 腫瘍由来の微小胞マーカーによる薬物感受性予測方法
Liao et al. Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody
JPWO2009084369A1 (ja) Hiv−1抗原の検出用試薬及び検出方法
US8021849B2 (en) Methods and kits for the determination of sirolimus in a sample
AU617334B2 (en) Cea immunoassay free of human anti-mouse antibody false positives
RU2701730C2 (ru) Способ прогнозирования риска развития рака или диагностирования рака у индивидуума
Yao et al. A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity
CN112079918A (zh) 一种h7n9病毒特异性识别抗体p51c05及检测试剂盒
Detrez et al. Characterization and application of a unique panel of monoclonal antibodies generated against etanercept